Point72 Hong Kong LTD Sol Gel Technologies Ltd. Transaction History

Point72 Hong Kong LTD

  • $1.34 Billion
  • Q2 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018
SELL
$6.2 - $7.8 $14,260 - $17,940
-2,300 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$7.5 - $10.71 $2,332 - $3,330
-311 Reduced 11.91%
2,300 $18,000
Q1 2018

May 15, 2018
BUY
$10.3 - $13.64 $26,893 - $35,614
2,611 New
2,611 $27,000

Others Institutions Holding SLGL

# of Institutions
4
Shares Held
123K
Call Options Held
0
Put Options Held
0
View Full List

About Sol-Gel Technologies Ltd.

SLGL Quotes by TradingView
  • Ticker SLGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,129,500
  • Market Cap $692M
  • Description
  • Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...
More about SLGL
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email